BRG Borregaard

Borregaard ASA: Invitation to Q4 2023 announcement

Borregaard ASA: Invitation to Q4 2023 announcement

24 January 2024: Borregaard ASA (”Borregaard”, OSE ticker: BRG)

Presentation of Q4 2023 results

Borregaard will report fourth quarter 2023 results on Wednesday 31 January 2024 at 07:00 CET. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on .

A presentation of the fourth quarter 2023 results will also be held at 08:30 CET at ABG Sundal Collier, Ruseløkkveien 26, 8th floor, Oslo. Attendance in person is possible. The presentation can be followed live on web-TV at . It will be possible to ask questions via the web.

All presentations will be held in English.

For more information about Borregaard ASA, please visit .

Contact:

Lotte Kvinlaug, Investor Relations Officer,

This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.

 



EN
24/01/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000. Start date: 12 December, 2025Maturity: 12 February, 2026Coupon: 4,43 %Organised by: DNB Carnegie Sarpsborg, 10 December 2025 Contact:CFO, Per Bjarne Lyngstad, +47 952 44 515 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioS...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch